News Releases

May 2, 2014

Bacai Inc. Issues Voluntary Worldwide Recall of LiteFit USA

The Missouri Department of Health and Senior Services received information regarding a recall of 13165 lot (lot number is found next to the expiration date) of LiteFit USA, to the retail and consumer level.

This product is used as an herbal diet supplement and is packaged in plastic bottles of 30 softgels. Sample analysis by the FDA has revealed that this product contained sibutramine. Risk Statement: Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.

Bacai is voluntarily recalling all LiteFit USA distribute by Bacai from June 26, 2013, to March 27, 2014 to the retail and consumer level. To date, Bacai has not received any reports of adverse events related to this recall. The affected LiteFit USA lots include the following lot number 13165, Expires: May 2017. LiteFit USA was distributed worldwide to wholesalers, retailers, and through the Internet. Bacai is notifying its distributors and customers by mail and is arranging for return and refunds of all LiteFit USA sold in the U.S. Consumers/distributors/retailers that have product which is being recalled should stop using and return it to the place of purchase.

Consumers with questions regarding this recall can contact Bacai by 714-775-0050 from 10 a.m. - 6 p.m. PDT.

The full recall can be found at: http://www.fda.gov/Safety/Recalls/ucm395538.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery.

###